Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): A randomised, double-blind, phase 3 trial

1. Ramalingam, S.S.
2. Jänne, P.A.
3. Mok, T.
4. O'Byrne, K.
5. Boyer, M.J.
6. Von Pawel, J.
7. Pluzanski, A.
8. Shtivelband, M.
9. Docampo, L.I.
10. Bennouna, J.
11. Zhang, H.
12. Liang, J.Q.
13. Doherty, J.P.
14. Taylor, I.
15. Mather, C.B.
16. Goldberg, Z.
17. O'Connell, J.
18. Paz-Ares, L.